All News
Interim Report Q1 2023
RegulatoryToday, AcouSort releases its interim report for Q1 2023. The report can be found in both Swedish and English here: AcouSort AB Q1 2023 SV AcouSort AB Q1 2023 ENG
Read MoreAcouSort is expanding its reach to flow cytometry with the ultimate goal of establishing in-line automated sample preparation
AcouSort’s unique technology offers significant improvements as to how cells are prepared prior to analysis. These improvements translate into higher sample quality which ultimately leads to decreasing the time and
Read MoreAcouSort launches next generation AcouTrap at CYTO 2023
CYTO is organized by the International Society for the Advancement of Cytometry and attended by leading researchers and instrumentation providers within flow cytometry. This year, AcouSort will use the conference
Read MoreAcouSort expands its reach to flow cytometry
AcouSort’s unique technology is finding its way into an increasing number of applications within research, diagnostics, and cell therapy. The latest example of this is a new collaboration with a
Read MoreInterview with Kelley Intehar, Sales Director North America
Can you tell us a bit about your training, background, and experience? I have worked with sales and sales management in the Life Science industry for almost 30 years. During
Read MoreThe prestigious US National Institute of Health becomes a returning customer to AcouSort
In 2017, the US National Institute of Health (NIH) purchased the first AcouWash prototype for the cell wash process in a new monitoring method for cancer treatments that they were
Read MoreKommuniké från årsstämma i AcouSort AB
RegulatoryIdag, den 25 april 2023, hölls årsstämma i AcouSort AB (publ). Nedan följer en sammanfattning av de beslut som fattades. Samtliga beslut fattades med erforderlig majoritet. AcouSort kommunike från
Read MoreAcouSort selected by EIC for participation in leading medical exhibition for the third time
AcouSort has been selected by the European Innovation Council (EIC) for participation in the European Pavilion at BIO 2023 in Boston, USA, after a highly competitive evaluation process. AcouSort is
Read MoreCzech research group sees novel opportunities for AcouWash in fish sperm refinement
During the fall of 2021, AcouSort was visited for one month by a PhD student from the Czech Republic working within fish reproduction. The purpose was to investigate if the
Read MoreThe stem cell therapy project Blue4Therapy brought to a highly successful close
The Blue4Therapy project was initiated in May 2020 with the ambition to develop clinical applications in cell therapy and stem cell treatments – two areas with great commercial potential for
Read More